MDLN

+ Watchlist + Portfolio

Medline Inc.

Regulated industry Physical products Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Fundamentals are temporarily unavailable for MDLN.

MDLN Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	—	—	—	$28.43B
Cost of Revenue	—	—	—	$20.91B
Gross Profit	—	—	—	$7.52B
Selling, General & Admin	—	—	—	$4.52B
Operating Expenses	—	—	—	$5.31B
Operating Income	—	—	—	$2.21B
EBITDA	—	—	—	$3.07B
Pretax Income	—	—	—	$1.25B
Income Tax	—	—	—	$91.00M
Net Income	—	—	—	$1.16B
Diluted EPS	-0.01	0.13	0.66	-0.01
Diluted Shares	1.83B	1.83B	1.83B	810.00M

MDLN Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$6.64B	—	—	$7.79B	$7.35B	$7.68B
Cost of Revenue	$4.82B	—	—	$5.87B	$5.51B	$5.47B
Gross Profit	$1.82B	—	—	$1.91B	$1.84B	$2.21B
Selling, General & Admin	$1.07B	—	—	$1.26B	$1.23B	$1.29B
Operating Expenses	$1.25B	—	—	$1.49B	$1.42B	$1.82B
Operating Income	$571.00M	—	—	$425.00M	$422.00M	$395.00M
EBITDA	$829.00M	$862.00M	—	$633.00M	$710.00M	$659.00M
Pretax Income	$338.00M	—	—	$206.00M	$291.00M	$235.00M
Income Tax	$16.00M	—	—	$26.00M	$52.00M	$96.00M
Net Income	$322.00M	—	—	$182.00M	$129.00M	$60.00M
Diluted EPS	0.18	0.42	0.18	-0.01	0.16	0.07
Diluted Shares	1.83B	799.80M	1.83B	810.00M	825.00M	861.00M

MDLN Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	—	—	—	$1.94B	$2.24B	$2.33B
Receivables	—	—	—	$3.53B	$3.67B	$3.66B
Inventory	—	—	—	$4.77B	$4.81B	$4.67B
Current Assets	—	—	—	$10.68B	$11.18B	$11.74B
Total Assets	—	—	—	$38.48B	$39.01B	$39.35B
Current Liabilities	—	—	—	$2.49B	$2.54B	$2.71B
Long-Term Debt	—	—	—	$12.48B	$12.49B	$12.55B
Total Debt	—	—	—	$12.63B	$12.64B	$12.64B
Total Liabilities	—	—	—	$19.20B	$19.66B	$20.27B
Retained Earnings	$0.00	—	—	-$7.00M	$122.00M	$182.00M
Shareholders' Equity	$16.52B	$128.00M	$127.00M	$10.74B	$11.27B	$11.57B
Working Capital	—	—	—	$8.19B	$8.64B	$9.03B
Net Debt	—	—	—	$10.62B	$10.34B	$10.25B

MDLN Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	—	$197.00M	—	$229.00M	$412.00M	$715.00M
Capital Expenditure	—	-$110.00M	—	-$138.00M	-$96.00M	-$111.00M
Free Cash Flow	—	$87.00M	—	$91.00M	$316.00M	$604.00M
Depreciation & Amortisation	—	$250.00M	—	$261.00M	$254.00M	$256.00M
Stock-Based Compensation	—	$15.00M	—	$27.00M	$23.00M	$29.00M
Investing Cash Flow	—	-$143.00M	—	-$138.00M	-$96.00M	-$461.00M
Financing Cash Flow	—	-$328.00M	—	$897.00M	-$13.00M	-$159.00M
Dividends Paid	—	—	—	-$96.00M	—	—
Share Repurchases	—	-$6.00M	—	-$1.97B	$0.00	$0.00
Net Change in Cash	—	-$274.00M	—	$988.00M	$303.00M	$95.00M

Market Snapshot

About

Medline Inc. is one of the largest privately-held medical supplies and healthcare products distributors in the United States. The company provides medical-surgical products, equipment, and clinical solutions to hospitals, long-term care facilities, home care agencies, and other healthcare providers across the continuum of care.